Cardiovascular magnetic resonance imaging in ischemic heart disease.
Ischemic heart disease is the most frequent etiology for cardiovascular morbidity and mortality. Early detection and accurate monitoring are essential to guide optimal patient treatment and assess the individual's prognosis. In this regard, cardiovascular magnetic resonance (CMR), which entered the arena of noninvasive cardiovascular imaging over the past two decades, became a very important imaging modality, mainly due to its unique versatility. CMR has proven accuracy and is a robust technique for the assessment of myocardial function both at rest and during stress. It also allows stress perfusion analysis with high spatial and temporal resolution, and provides a means by which to differentiate tissue such as distinguishing between reversibly and irreversibly injured myocardium. In particular, the latter aspect is a unique benefit of CMR compared with other noninvasive imaging modalities such as echocardiography and nuclear medicine, and provides novel information concerning the presence, size, transmurality, and prognosis of myocardial infarction. This article is intended to provide the reader with an overview of the various applications of CMR for the assessment of ischemic heart disease from a clinical perspective.
Working Group on Cardiovascular Magnetic Resonance, Medical University Berlin, Experimental Clinical Research Center, a joint cooperation of the Charité and the Max-Delbrueck-Center, Berlin, Germany.
Florian
F
von Knobelsdorff-Brenkenhoff
Jeanette
J
Schulz-Menger
D003324:Coronary Artery Disease / Q000150:complications* / Q000175:diagnosis*; D006801:Humans; D018810:Magnetic Resonance Angiography / Q000379:methods*; D019028:Magnetic Resonance Imaging, Cine / Q000379:methods*; D017202:Myocardial Ischemia / Q000175:diagnosis* / Q000209:etiology*; D055414:Myocardial Perfusion Imaging / Q000379:methods*